← Browse by Condition
Medical Condition

angina pectoris

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for angina pectoris sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — angina pectoris Clinical Trials

How many clinical trials are currently recruiting for angina pectoris?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for angina pectoris, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for angina pectoris?
angina pectoris research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a angina pectoris clinical trial?
Eligibility criteria for angina pectoris trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Universitas Padjadjaran 1 trial
Biotronik AG 1 trial
Stanford University 1 trial

Recruiting Clinical Trials

NCT04873687
Recruiting
Effectiveness of ECP Therapy in Stable Angina Pectoris Patients
Enrollment
84 pts
Location
Indonesia
Sponsor
Universitas Padjadjaran
View Trial →
NCT05540223
Recruiting
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System
Enrollment
1,859 pts
Location
Germany
Sponsor
Biotronik AG
View Trial →
NCT06424834 Phase 2, Phase 3
Recruiting
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Enrollment
150 pts
Location
United States
Sponsor
Stanford University
View Trial →

Related Conditions

counterpulsation (1) coronary artery disease (1) atherosclerosis coronary (1) myocardial ischemia (1) ischemic heart disease (1) acute coronary syndrome (1) microvascular angina (1) vasospastic angina (1) myocardial bridge of coronary artery (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology